← Back to Search

Behavioural Intervention

CBT + tDCS for Obsessive-Compulsive Disorder

Led By Bradley C Riemann, PhD
Research Sponsored by Rogers Behavioral Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Screening 3 weeks
Treatment Varies
Follow Up up to 12 weeks
Awards & highlights

Study Summary

This trial compares the effects of tDCS and sham stimulation before CBT on OCD symptoms. Investigator thinks tDCS may lead to greater improvements.

Who is the study for?
This trial is for Wisconsin residents with a primary diagnosis of OCD who are enrolled in the Intensive Outpatient Program at Rogers Behavioral Health. Participants must speak and understand English well. It's not open to those with metal in their body, cranial pathologies, pregnant individuals, previous patients of Rogers Behavioral Health, or those on certain seizure threshold-lowering meds.Check my eligibility
What is being tested?
The study tests if brain stimulation (tDCS) before cognitive-behavioral therapy helps more than fake stimulation (sham tDCS) in improving OCD symptoms. The hypothesis is that active brain stimulation will lead to better outcomes compared to sham treatment.See study design
What are the potential side effects?
Potential side effects from tDCS may include mild tingling, itching or discomfort at the electrode site on the scalp, fatigue, headache or nausea. These are usually temporary and often resolve soon after treatment.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Quick Inventory of Depressive Symptomology from admission to discharge
Change in Yale-Brown Obsessive-Compulsive Scale - Self-Report from admission to discharge
Secondary outcome measures
Change in Intolerance of uncertainty scale from admission to discharge
Change in Obsessive-Compulsive Inventory-Revised from admission to discharge
Change in Quality of life enjoyment and satisfaction questionnaire - short form from admission to discharge
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Active stimulationExperimental Treatment1 Intervention
Group II: Sham stimulationPlacebo Group1 Intervention
First Studied
Drug Approval Stage
How many patients have taken this drug
transcranial direct current stimulation
Completed Phase 3

Find a Location

Who is running the clinical trial?

Rogers Behavioral HealthLead Sponsor
2 Previous Clinical Trials
1,200 Total Patients Enrolled
Bradley C Riemann, PhDPrincipal InvestigatorRogers Behavioral Health

Media Library

CBT With tDCS (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05964998 — N/A
Obsessive-Compulsive Disorder Research Study Groups: Active stimulation, Sham stimulation
Obsessive-Compulsive Disorder Clinical Trial 2023: CBT With tDCS Highlights & Side Effects. Trial Name: NCT05964998 — N/A
CBT With tDCS (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05964998 — N/A
~13 spots leftby Aug 2025